0718B |
Brivaracetam, Blood |
0718SP |
Brivaracetam, Serum/Plasma |
0970B |
Carbamazepine and Metabolite, Blood |
0970FL |
Carbamazepine and Metabolite, Fluid |
0970SP |
Carbamazepine and Metabolite, Serum/Plasma |
0970TI |
Carbamazepine and Metabolite, Tissue |
0971SP |
Carbamazepine and Metabolite - Free, Serum/Plasma |
0972SP |
Carbamazepine and Metabolite - Total/Free/Bound, Serum/Plasma |
0975SP |
Carbamazepine-10,11-Epoxide, Serum/Plasma |
0975U |
Carbamazepine-10,11-Epoxide, Urine |
1056B |
Cenobamate, Blood |
1056SP |
Cenobamate, Serum/Plasma |
1858B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
1858FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1861B |
Drugs of Abuse Screen (7 Panel), Blood |
1861U |
Drugs of Abuse Screen (6 Panel), Urine |
1864B |
Drugs of Abuse Screen (11 Panel), Blood |
1864FL |
Drugs of Abuse Screen (11 Panel), Fluid |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1864TI |
Drugs of Abuse Screen (11 Panel), Tissue |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874B |
Drug Screen (10 Panel), Blood |
1874U |
Drug Screen (9 Panel), Urine |
1876B |
Drug Screen - Expanded, Blood |
1876FL |
Drug Screen - Expanded, Fluid |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
1876U |
Drug Screen - Expanded, Urine |
2000B |
Ethosuximide, Blood |
2000SP |
Ethosuximide, Serum/Plasma |
2000U |
Ethosuximide, Urine |
2010B |
Ethotoin, Blood |
2010SP |
Ethotoin, Serum/Plasma |
2069B |
Felbamate, Blood |
2069SP |
Felbamate, Serum/Plasma |
2136B |
Fosphenytoin as Metabolite, Blood |
2136SP |
Fosphenytoin as Metabolite, Serum/Plasma |
2187SP |
Ganaxolone, Serum/Plasma |
2484B |
Lamotrigine, Blood |
2484SP |
Lamotrigine, Serum/Plasma |
2484U |
Lamotrigine, Urine |
2505B |
Levetiracetam, Blood |
2505SP |
Levetiracetam, Serum/Plasma |
2527B |
Lacosamide, Blood |
2527FL |
Lacosamide, Fluid |
2527SP |
Lacosamide, Serum/Plasma |
2527U |
Lacosamide, Urine |
2950B |
Methsuximide as Metabolite, Blood |
2950SP |
Methsuximide as Metabolite, Serum/Plasma |
3265B |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Blood |
3265SP |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Serum/Plasma |
3310B |
Paraldehyde and Metabolite, Blood |
3310SP |
Paraldehyde and Metabolite, Serum/Plasma |
3310U |
Paraldehyde and Metabolite, Urine |
3320SP |
Paramethadione, Serum/Plasma |
3433SP |
Perampanel, Serum/Plasma |
3707B |
Phenylethylmalonamide, Blood |
3707SP |
Phenylethylmalonamide, Serum/Plasma |
3743B |
Phenytoin, Blood |
3743FL |
Phenytoin, Fluid |
3743SP |
Phenytoin, Serum/Plasma |
3743TI |
Phenytoin, Tissue |
3901SP |
Primidone, Serum/Plasma |
4025SP |
Ezogabine and Metabolite, Serum/Plasma |
4125B |
Rufinamide, Blood |
4125SP |
Rufinamide, Serum/Plasma |
4211B |
Stiripentol, Blood |
4211SP |
Stiripentol, Serum/Plasma |
4479B |
Tiagabine, Blood |
4479SP |
Tiagabine, Serum/Plasma |
4519B |
Topiramate, Blood |
4519FL |
Topiramate, Fluid |
4519SP |
Topiramate, Serum/Plasma |
4519U |
Topiramate, Urine |
4700B |
Trimethadione and Metabolite, Blood |
4700SP |
Trimethadione and Metabolite, Serum/Plasma |
4700U |
Trimethadione and Metabolite, Urine |
4757B |
Valproic Acid, Blood |
4757FL |
Valproic Acid, Fluid |
4757SP |
Valproic Acid, Serum/Plasma |
4757TI |
Valproic Acid, Tissue |
4757U |
Valproic Acid, Urine |
4759SP |
Valproic Acid - Unbound and Total, Serum/Plasma |
4761SP |
Valproic Acid, Unbound, Serum/Plasma |
4774SP |
Vigabatrin, Serum/Plasma |
4884SP |
Zonisamide, Serum/Plasma |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
6946H |
Drugs of Abuse Screen (9 Panel), Hair |
8050U |
Postmortem, Urine Screen Add-On (6-MAM Quantification only) (Forensic) Overview: Add-On Test |
8061B |
Postmortem, Basic w/o Alcohol, Blood (Forensic) |
8061TI |
Postmortem, Basic w/o Alcohol, Tissue (Forensic) |
8061U |
Postmortem, Basic w/o Alcohol, Urine (Forensic) |
8070U |
DUID/DRE Panel (w/Alcohol) (Qualitative), Urine (Forensic) |
8071U |
DUID/DRE Panel (Qualitative), Urine (Forensic) |
8083B |
Postmortem, Basic w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
8098B |
Drug Screen (GC/MS), Blood |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
8150B |
DUID/DRE Panel, Blood (Forensic) |
8151B |
DUID/DRE Panel (w/Alcohol), Blood (Forensic) |
8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
8170U |
DUID/DRE Panel (w/Alcohol), Urine (Forensic) |
8171U |
DUID/DRE Panel, Urine (Forensic) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9171B |
Ethosuximide Screen, Blood |
9171SP |
Ethosuximide Screen, Serum/Plasma |
9171U |
Ethosuximide Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |